This website is intended for healthcare professionals
This website is intended for healthcare professionals
Concerns about the dangers of SACT began to emerge in the 1970s when second malignancies were first reported in cancer patients treated with alkylating agents, explained Dr Melissa McDiarmid,...
‘Biologically important exposure [to hazardous drugs] is occurring in the oncology work setting’, Dr Melissa McDiarmid (Professor of Medicine and Epidemiology, University of Maryland School of...
Hazardous drugs deserve deep respect in their handling, due to their toxicity, but some concerns could be allayed by implementing a comprehensive set of exposure controls, according to Dr Melissa...
‘Systemic anticancer therapy (SACT) comprises a wide range of treatments, but in the context of occupational exposure and protection of nurses, the debate is firmly focused on cytotoxics and...
Alison Simons and Samantha Toland (Senior Lecturers at Birmingham City University) have a special interest in SACT safety and the protection of nurses administering chemotherapy..
The panel agreed that, in their experience, the inclusion of items on formulary was decided by nurses, within a set budget, based on the clinical needs of a patient population with moderate to severe...
The chair opened the discussion by inviting the panel members to estimate how often they saw peristomal skin-related complications in their daily practice. One delegate mentioned that up to 80% of...
BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.
Clinical expertise
Peer-reviewed research
Best practice guidance
CPD support